Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer a systematic evidence review for the U.S. Preventive Services Task Force

Trials of vitamin E supplementation showed mixed results and altogether had no overall effect on cancer, CVD, or all-cause mortality. Only one of two included selenium trials showed a beneficial effect for colorectal and prostate cancer; however, this trial included a small sample size. The few stud...

Full description

Bibliographic Details
Main Author: Fortmann, Stephen P.
Corporate Authors: Oregon Evidence-based Practice Center (Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region)), U.S. Preventive Services Task Force, United States Agency for Healthcare Research and Quality
Format: eBook
Language:English
Published: Rockville, MD Agency for Healthcare Research and Quality 2013, 2013
Series:Evidence synthesis
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 05105nam a2200385 u 4500
001 EB000943899
003 EBX01000000000000000737489
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
100 1 |a Fortmann, Stephen P. 
245 0 0 |a Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer  |h Elektronische Ressource  |b a systematic evidence review for the U.S. Preventive Services Task Force  |c prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by Kaiser Permanente Research Affiliates Evidence-based Practice Center, Kaiser Permanente Center for Health Research ; investigators, Stephen P. Fortmann, Brittany U. Burda, Caitlyn A. Senger, Jennifer S. Lin, Tracy L. Beil, Elizabeth O'Connor, Evelyn P. Whitlock 
260 |a Rockville, MD  |b Agency for Healthcare Research and Quality  |c 2013, 2013 
300 |a 1 PDF file (vii, 178 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Vitamins / therapeutic use 
653 |a United States 
653 |a Primary Prevention 
653 |a Dietary Supplements 
653 |a Minerals / therapeutic use 
653 |a Cardiovascular Diseases / prevention & control 
653 |a Neoplasms / prevention & control 
710 2 |a Oregon Evidence-based Practice Center (Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region)) 
710 2 |a U.S. Preventive Services Task Force 
710 2 |a United States  |b Agency for Healthcare Research and Quality 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Evidence synthesis 
500 |a Title from PDF title page 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK173987/pdf/TOC.pdf  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a Trials of vitamin E supplementation showed mixed results and altogether had no overall effect on cancer, CVD, or all-cause mortality. Only one of two included selenium trials showed a beneficial effect for colorectal and prostate cancer; however, this trial included a small sample size. The few studies addressing folic acid, vitamin C, and vitamin A showed no effect on CVD, cancer, and mortality. Vitamin D and/or calcium supplementation also showed no overall effect on CVD, cancer, and mortality. Harms were infrequently reported and aside from limited paradoxical effects for some supplements, were not considered serious. CONCLUSIONS: There are a limited number of trials examining the effects of dietary supplements on the primary prevention of CVD and cancer; the majority showed no effect in healthy populations. Clinical heterogeneity of included studies limits generalizability of results to the general primary care population.  
520 |a One investigator abstracted data into an evidence table and a second investigator checked these data. We qualitatively and quantitatively synthesized the results for the four key questions and grouped the included studies by study supplement. We conducted meta-analyses using Mantel-Haenzel fixed effects models for overall cancer incidence, CVD incidence, and all-cause mortality. RESULTS: We included 103 articles representing 26 unique studies. Very few studies examined the use of multivitamin supplements. Two trials showed a protective effect against cancer in men; only one of these trials included women and found no effect. No effects of treatment were seen on CVD or all-cause mortality. Beta-carotene showed a negative effect on lung cancer incidence and mortality among individuals at high risk for lung cancer at baseline (i.e., smokers and asbestos-exposed workers); this effect was persistent even when combined with vitamin A or E.  
520 |a Results from trials in at-risk populations discourage additional studies for particular supplements (e.g., beta-carotene); however, future research in general primary care populations and on other supplements is required to address research gaps 
520 |a BACKGROUND: In the United States, dietary supplements are commonly used to prevent chronic diseases, including cardiovascular disease (CVD) and cancer. PURPOSE: To systematically review evidence for the use of multivitamins or single nutrients and functionally related nutrient pairs for the prevention of CVD and cancer in the general population (primary prevention). METHODS: We searched MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects, and Cochrane Central Register of Controlled Trials to identify literature that was published between 2005 and January 29, 2013. We also examined the references from the previous reviews and other relevant reviews to identify additional studies; we also searched Web sites of government agencies and other organizations for grey literature. Two investigators independently reviewed identified abstracts and full-text articles against a set of a priori inclusion and quality criteria.